Cue Health rises after disclosing potential sale part of strategic options

Cue Health

09/04/2024 15:37

** Shares of medical testing company Cue Health Inc  HLTH.O 
rise 3.15 % to 18 cents 
    ** Co discloses in a regulatory filing that it has been
undertaking a comprehensive review of strategic alternatives,
including a potential sale of company
    ** Co had cash and cash equivalent of $80.9 mln as of Dec.
31
    ** Also, says it has been informed by the US FDA that its
RSV (respiratory syncytial virus) molecular test does not meet
the criteria for over-the-counter (OTC) use under either Class I
or Class II classification
    ** Including the session moves, stock up about 13.11% YTD

 (Reporting by Judes Joseph in Bengaluru)
 ((judes.joseph@thomsonreuters.com;))